IMMUNE MEDIATED COMPLETE RESPONSE IN A PATIENT WITH RECURRENT ADVANCED EWING’S SARCOMA (EWS) FOLLOWING VIGIL® IMMUNOTHERAPY

Wednesday, July 26, 2017